Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States

Long-Term Direct Costs Before and After Proctocolectomy for Ulcerative Colitis: A Population-Based Study in Olmsted County, Minnesota

(2011) Stefan D. Holubar et al.   DISEASES OF THE COLON & RECTUM

Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults

(2010) J. LINDSAY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates

(2009) Joel H Rubenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Cost Effectiveness of Alternative Imaging Strategies for the Diagnosis of Small-Bowel Crohn's Disease

(2009) Barrett G. Levesque et al.   Clinical Gastroenterology and Hepatology

Algorithms Outperform Metabolite Tests in Predicting Response of Patients With Inflammatory Bowel Disease to Thiopurines

(2009) Akbar K. Waljee et al.   Clinical Gastroenterology and Hepatology

Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis

(2009) Geoffrey C. Nguyen et al.   GASTROINTESTINAL ENDOSCOPY

Cost-effectiveness of Quantitative Fecal Lactoferrin Assay for Diagnosis of Symptomatic Patients With Ileal Pouch-anal Anastomosis

(2009) Mansour A. Parsi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Health Care Expenditures in Ulcerative Colitis: The Perspective of a Self-Insured Employer

(2009) Eric Hillson et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohnʼs Disease

(2009) Andrew P. Yu et al.   PHARMACOECONOMICS

The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

(2008) A. BUCKLAND et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

(2008) H. H. TSAI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

(2008) P. D. R. HIGGINS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis

(2008) Shekoufeh Nikfar et al.   DIGESTIVE DISEASES AND SCIENCES

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

Effects of fistula on healthcare costs and utilization for patients with Crohnʼs disease treated in a managed care environment

(2008) Russell D. Cohen et al.   INFLAMMATORY BOWEL DISEASES

Impact of ulcerative colitis from patientsʼ and physiciansʼ perspectives

(2008) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

The Direct and Indirect Cost Burden of Crohnʼs Disease and Ulcerative Colitis

(2008) Teresa B. Gibson et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

(2008) Eric Qiong Wu et al.   VALUE IN HEALTH